Leerink Partners
Will S. is currently working as an Equity Research Vice President at Leerink Partners, focusing on SMID-cap biotechs with a focus on Rare Disease. Prior to this role, Will S. gained experience as an Equity Research Associate and Intern at various companies such as Angelo Gordon and G2 Capital Advisors/G2 Securities. Will S. holds a Bachelor's Degree from Colby College and has completed the Business Bridge Program at The Tuck School of Business at Dartmouth.
This person is not in the org chart
Leerink Partners
1 followers
Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority. SVB Securities LLC is doing business as Leerink Partners.